Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000080255-26-000281·PRICE T ROWE ASSOCIATES INC /MD/
Schedule 13G ownership disclosure
Vera Therapeutics Inc
COMMON STOCK · CUSIP: 92337R101
Event date: 2025-12-31
- Filing-level shares
- 5,461,988
- Percent of class
- 7.7%
- T. Rowe Price Associates, Inc.
Shares: 5,461,988 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-26-000281
- Form type
- SCHEDULE 13G/A
- Filer
- PRICE T ROWE ASSOCIATES INC /MD/
- CIK
- CIK 80255
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership